Global Patient Blood Management Market was valued at USD 10.22 billion in 2019 which is expected to reach USD 16.88 billion by 2030 at a CAGR 7.8%.
Patient blood management is also called as (PBM) and it is standard plan for management of a patient’s blood to reduce the blood loss during surgery, optimize patient blood, and optimize tolerance of anemia. Patient blood management is a standard care plan which is performed by medical practitioners for patients.
Increase in prevalence of targeted diseases is the driving factor which is expected to drive the global patient blood management market growth. Furthermore, rise in awareness regarding blood donation among people will have the positive impact on global patient blood management market growth. For instance, in 2017, according to National Health Commission (NHC) around 14.59 million people had donated blood across the world. Moreover, increase in demand for donated blood across the world which is expected to fuel the global patient blood management market growth. Also, increase in technological advancements is expected to propel the growth of patient blood management industry during this forecast period.
However, high cost of automated systems is the restraining factor which is expected to hamper the global patient blood management market.
Global Patient Blood Management Market is segmented into product such as Blood Transfusion Devices, Blood Processing Devices, Diagnostic and Testing Instruments, Blood Storage Devices, and Blood Culture Screening Devices, by component such as Plasma, and Whole Blood. Further, Global Patient Blood Management Market is segmented into end user such as Diagnostic Clinic & Pathology Labs, Hospitals, and Blood Banks.
Also, Global Patient Blood Management Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Various key players are discussed in this report such as Grifols, S.A., Abbott Laboratories, Bio-Rad Laboratories, Inc., Kaneka Corporation, Biomérieux SA, Macopharma, B. Braun Melsungen AG, Immucor, Inc., Terumo Corporation, Fresenius Se & Co. KGaA, and Haemonetics Corporation.
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Patient Blood management Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Patient Blood management Market, By Product
5.1 Y-o-Y Growth Comparison, By Product
5.2 Global Patient Blood management Market Share Analysis, By Product
5.3 Global Patient Blood management Market Size and Forecast, By Product
5.3.1 Blood Transfusion Devices
5.3.2 Blood processing Devices
5.3.3 Diagnostic and Testing Instruments
5.3.4Blood Storage Devices
5.3.5Blood Culture Screening Devices
6 Global Patient Blood management Market, By Component
6.1 Y-o-Y Growth Comparison, By Component
6.2 Global Patient Blood management Market Share Analysis, By Component
6.3 Global Patient Blood management Market Size and Forecast, By Component
6.3.1 Plasma
6.3.2 Whole Blood
7 Global Patient Blood management Market, By End User
7.1 Y-o-Y Growth Comparison, By End User
7.2 Global Patient Blood management Market Share Analysis, By End User
7.3 Global Patient Blood management Market Size and Forecast, By End User
7.3.1 Diagnostic Clinic & Pathology Lab
7.3.2 Hospitals
7.3.3Blood Banks
8 Global Patient Blood management Market, By Region
8.1 Global Patient Blood management Market Share Analysis, By Region
8.2 Global Patient Blood management Market Share Analysis, By Region
8.3 Global Patient Blood management Market Size and Forecast, By Region
9 North America Patient Blood management Market Analysis and Forecast (2017 – 2030)
9.1 Introduction
9.2 North America Patient Blood management Market Share Analysis, By Product
9.3 North America Patient Blood management Market Size and Forecast, By Component
9.4 North America Patient Blood management Market Size and Forecast, By End User
9.5 North America Patient Blood management Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 Europe Patient Blood management Market Analysis and Forecast (2017 – 2030)
10.1 Introduction
10.2 Europe Patient Blood management Market Share Analysis, By Product
10.3 Europe Patient Blood management Market Size and Forecast, By Component
10.4 Europe Patient Blood management Market Size and Forecast, By End User
10.5 Europe Patient Blood management Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.5.4. Rest of Europe
11 Asia Pacific Patient Blood management Market Analysis and Forecast (2017 – 2030)
11.1 Introduction
11.2 Asia Pacific Patient Blood management Market Share Analysis, By Product
11.3 Asia Pacific Patient Blood management Market Size and Forecast, By Component
11.4 Asia Pacific Patient Blood management Market Size and Forecast, By End User
11.5 Asia Pacific Patient Blood management Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12 Latin America Patient Blood management Market Analysis and Forecast (2017 – 2030)
12.1 Introduction
12.2 Latin America Patient Blood management Market Share Analysis, By Product
12.3 Latin America Patient Blood management Market Size and Forecast, By Component
12.4 Latin America Patient Blood management Market Size and Forecast, By End User
12.5 Latin America Patient Blood management Market Size and Forecast, Country
13 Middle East Patient Blood management Market Analysis and Forecast (2017 – 2030)
13.1 Introduction
13.2 Middle East Patient Blood management Market Share Analysis, By Product
13.3 Middle East Patient Blood management Market Size and Forecast, By Component
13.4 Middle East Patient Blood management Market Size and Forecast, By End User
13.5 Middle East Patient Blood management Market Size and Forecast, By Country
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Grifols, S.A
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Abbott Laboratories
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 Bio-Rad Laboratories, Inc
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Kaneka Corporation
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Biomérieux SA
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Macopharma,
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 B. Braun Melsungen AG
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Immucor, Inc
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Terumo Corporation
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Fresenius Se & Co. KGaA
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
15.11 Haemonetics Corporation
15.11.1 Overview
15.11.2 Offerings
15.11.3 Key Financials
15.11.4 Business Segment & Geographic Overview
15.11.5 Key Market Developments
15.11.6 Key Strategies
